Pakistan's Guidelines on Therapeutic Good Import & Export Permissions
USFDA Electronic Submission of IND Safety Reports - Technical Conformance Guide
USFDA Guidance on Electronic PostMarketing Safety Reporting
Guidance on Classification of Rehabilitation Medical Devices -Malaysia’s MDA
Guidelines on Labeling Requirements of Drug Products under Maximum Retail Price - Philippines FDA
USFDA Guidance on “Pharm. Quality/CMC Data Exchange" and Drug Products containing Nanoparticles
SFDA's Product Classification Guidance
Pakistan (DRAP) Draft Guidelines on FP Labeling & Packaging and BA-BE Guidelines
Malaysia’s MDA- Draft Medical Device Labeling Guidance
FDA's Considerations for Waiver Requests for pH Adjusters in Generic Drug Products
FDA's Bioavailability Guidance for NDAs or INDs- General consideration
Draft Guidleline on Change Notification For Registered Medical Device-Malaysia’s MDA
FDA's MAPP on Complex Product Classification for Generic Development
HPRA Guide to Parallel Imports of Human Medicines - Ireland
FDA's Draft Guidance on Cybersecurity in MD: Quality System Consideration & Content of Premarket Sub
EMA Draft Guidance- How To Approach the Protection Clinical Trial Information System (CTIS)
ICH-Draft Guideline on Pediatric Extrapolation & FInal Guidance on Considerations for Clinical Study
Voluntary GVP Inspection on Pharma Product Registration Holders- Malaysia’s NPRA